Annovis Bio
ANVS
40 hedge funds and large institutions have $7.93M invested in Annovis Bio in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 4 closing their positions.
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
14% more funds holding
Funds holding: 35 → 40 (+5)
2.38% more ownership
Funds ownership: 9.03% → 11.42% (+2.4%)
17% less capital invested
Capital invested by funds: $9.5M → $7.93M (-$1.58M)
41% less call options, than puts
Call options by funds: $1.99M | Put options by funds: $3.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$814K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$623K |
| 3 |
MFG
Merit Financial Group
Alpharetta,
Georgia
|
+$520K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$372K |
| 5 |
Jane Street
New York
|
+$347K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
A
AlphaQuest
New York
|
-$371K |
| 2 |
D.E. Shaw & Co
New York
|
-$197K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$192K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$109K |
| 5 |
SIAP
Sterling Investment Advisors (Pennsylvania)
Berwyn,
Pennsylvania
|
-$76K |
ANVS Hedge Fund Activity: Q4 2024 in Review
40 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2024, worth a combined $7.93M — down 17% from $9.5M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ANVS positions and 4 closed out — a net gain of 5 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $814K. The largest seller was AlphaQuest, exiting entirely with an estimated $371K sold.
- 40 institutional investors held Annovis Bio (ANVS) as of Q4 2024, up from 35 in Q3 2024.
- Funds reported $7.93M of Annovis Bio stock for Q4 2024, down 17% quarter-over-quarter.
- 9 funds opened new Annovis Bio positions in Q4 2024 and 4 closed out, a net change of +5 holders.
- The largest Annovis Bio buyer in Q4 2024 was Citadel Advisors, an estimated $814K added.
- The largest Annovis Bio seller in Q4 2024 was AlphaQuest, an estimated $371K sold.
Based on aggregated 13F filings for Q4 2024.